Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Schering
NERISONE FORTE SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): NERISONE FORTE OINTMENT NERISONE FORTE FATTY OINTMENT COMPOSITION 1 g Nerisone Forte contains diflucortolone valerate (6alpha,9-difluoro-11beta-hydroxy-21-valeryloxy-16alpha-methyl- 1,4-pregnadiene-3,20-dione) 3 mg (0,3%). PHARMACOLOGICAL CLASSIFICATION A. 13.4.1 Corticosteroids without anti-infective agents. PHARMACOLOGICAL ACTION Nerisone Forte is a preparation of diflucortolone valerate. Nerisone Forte suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints, such as itching, burning and pain. INDICATIONS Psoriasis vulgaris, neurodermatitis, eczema, lichen ruber planus et verrucosus (pityriasis rubra pilarus), erythematodes chronicus discoides (discoid lupus erythematosus), severe conditions of chronic eczema. CONTRA-INDICATIONS Tuberculous and syphilitic processes in the area to be treated, virus diseases (herpes simplex, vaccinia, varicella and smallpox). The preparations should never be applied to the face or any skin crease areas. Corticosteroids have been shown to be teratogenic in animals following dermal application. As these agents are absorbed percutaneously, teratogenicity following topical application cannot be excluded. Therefore Nerisone Forte should not be used during pregnancy. DOSAGE AND DIRECTIONS FOR USE Nerisone Forte ointment and fatty ointment must not be used for periods exceeding 2 weeks. Unless otherwise prescribed, Nerisone Forte is applied thinly twice a day. For further treatment, a switch should be made to a less potent topical corticosteroid preparation. Nerisone Forte is available in two bases: Nerisone Forte ointment and Nerisone Forte fatty ointment. Which form should be used in the individual case will depend on the appearance of the skin: Nerisone Read the complete document